Clinical Trial Update: The Platelet Aggregation After tiCagrelor Inhibition and FentanYl Trial (PACIFY) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial PACIFY evaluated platelet aggregation after ticagrelor inhibition in the context of fentanyl use in patients with coronary artery disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• FENTANYL (FENTANYL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Johns Hopkins University | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2018-05-09